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We describe a mumps outbreak in a highly-vaccinated 
population attending a party at a youth club. In a ret-
rospective cohort study with 60 of approximately 100 
participants responding, vaccination status was veri-
fied for 58/59 respondents, of whom 54 were vacci-
nated twice and four once. The attack rate was 22% (13 
cases, all vaccinated), with smoking at the party (risk 
ratio (RR) 3.1; 95% confidence interval (CI): 1.6–6.0, 
p=0.001) and age ≥21 years (RR 4.7; 95% CI: 2.1–10.2, 
p<0.0001) as risk factors for disease in the binominal 
regression analysis. Mild upper respiratory illness was 
also highly prevalent in those who did not meet the 
mumps case definition (n=46) after the party, suggest-
ing that mumps virus infection may cause mild disease 
in vaccinated individuals. Our investigation adds to 
evidence that crowded social events and smoking may 
facilitate spread of mumps virus among vaccinated 
populations, with waning immunity playing a role. The 
suggestion that mumps virus infection in vaccinated 
individuals may manifest as mild upper respiratory 
illness could have implications for transmission and 
warrants further investigation.
Introduction 
Mumps is caused by a paramyxovirus infection and is 
characterised by acute swelling of the parotid and other 
salivary glands. Although usually mild, complications 
such as orchitis, pancreatitis, meningitis and deafness 
can occur. Routine mumps vaccination has been imple-
mented in the Netherlands since a measles-mumps-
rubella (MMR) vaccine containing the Jeryl Lynn virus 
strain was introduced into the National Immunisation 
Programme in 1987. This vaccine is offered as a two-
dose schedule at 14 months and nine years of age. 
Although vaccination coverage with two doses has con-
sistently exceeded 93% [1], several outbreaks in highly 
vaccinated populations have occurred recently, partic-
ularly in students [2-4]. These incidents contribute to 
growing evidence that high vaccine coverage may not 
suffice to prevent outbreaks [5,6].
In spring 2012, a mumps outbreak occurred in a Dutch 
village with 25 cases notified to the municipal health 
service (MHS). Dates of onset for the notified cases 
ranged from 17 February to 2 April 2012, and three of 
these cases were laboratory-confirmed as infected 
with mumps virus genotype G5. Of 23 cases who could 
be contacted by the MHS, 22 were confirmed to have 
been vaccinated twice (the remaining case was born 
outside the Netherlands and had no accessible vaccina-
tion record). Eighteen of the 23 cases reported attend-
ing a party with approximately 100 guests at a youth 
club on 9 March 2012. We conducted a retrospective 
cohort study to investigate attack rates (AR) and risk 
factors for mumps disease at the party, and to explore 
the hypothesis that infection of vaccinated individuals 
may manifest as mild upper respiratory illness (URI).
Methods
We used an online questionnaire (Questback), publi-
cised largely through social media, and active from 4 
May to 4 June 2012, to collect information from party 
attendees regarding demographics, vaccination sta-
tus, party-related activities (see Table 1), mumps his-
tory, and symptoms of mild upper respiratory illness/
mumps-like illness within 25 days of the party (the 
maximum incubation period) and also at the time they 
completed the questionnaire [7]. We defined cases as 
respondents with self-reported mumps (swelling of 
one/both cheeks with symptoms lasting ≥ two days) 
within 12 to 25 days after the party (the minimum and 
maximum incubation period), i.e. between 21 March 
and 3 April 2012. Vaccination status was verified 
using the national register. We explored associations 
between risk factors and mumps using univariable 
analysis and then binomial regression, entering all var-
iables with p<0.20 into the model. To investigate the 
prevalence of mild respiratory illness around the time 
of the outbreak, we used McNemar’s test to compare 
the prevalence of URI-specific (runny nose, sore throat, 
cough, and swollen cervical lymph nodes) and other 
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symptoms (stomach ache, myalgia, fever and loss of 
appetite) within 25 days of the party to the point preva-
lence of these symptoms at time of questionnaire com-
pletion, excluding mumps cases from this analysis. We 
performed analysis using Stata 11. The study adhered 
to national ethical guidelines for health research [8-10].
Results
In total, 60 eligible questionnaires were returned. The 
exact number of people who attended the party is not 
known, but was estimated to be about 100. We do not 
know how many people saw the questionnaire, but 
the approximated response rate is 60%.  One individ-
ual with confirmed mumps with date of onset before 
January 2012 was excluded from analyses. The age 
range of the respondents was 15–25 years old (median 
18), and 51% were male (n=30). Vaccination status was 
verified for 58/59 (98%) respondents, of whom 54 were 
known to have been vaccinated twice and four at least 
once. The remaining respondent’s vaccination status 
was unknown. Thirteen respondents met our case defi-
nition for mumps, equivalent to an AR of 22%. Nine of 
these cases had been notified to the MHS. One case 
had been laboratory-confirmed and eight reported 
confirmation by a physician. Incubation period ranged 
from 13 to 24 days (i.e. date of onset between 22 
March and 2 April 2012), with a median of 18 days and 
a peak at 17–18 days (27–28 March 2012, see Figure). 
All 13 cases had been vaccinated twice. None of the 
Table 1
Questions about party-related activities included in questionnaire sent to people who had attended a youth club party in a 
village in the Netherlands on 9 March 2012
Activity Possible response
Time of arrival at party HH:MM (24h clock)
Time of departure from party HH:MM (24h clock)




Did you spend time with friends before going to the party? Y/N
Did you go to another party/bar after leaving the youth club party? Y/N
During the party, did you do any of the following things:
Smoke a cigarette Y/N/Don’t know or prefer not to say
Share a cigarette/cannabis joint Y/N/Don’t know or prefer not to say
Share a drink (e.g drink from a glass or bottle that another person had used) Y/N/Don’t know or prefer not to say
Share food with someone (e.g. use a fork or plate that another person had used) Y/N/Don’t know or prefer not to say
Kiss someone Y/N/Don’t know or prefer not to say
N: no; Y:yes.
Figure
Number of cases of mumps associated with attending a village youth club party on 9 March 2012, by date of symptom 
onset, the Netherlands, March–April 2012 (n=11)




















Date of symptom onset 
March 2012
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respondents reported complications (meningitis, orchi-
tis, pancreatitis or deafness) or hospitalisation.  
Table 2 shows the results of the univariable and mul-
tivariable analyses. Respondents aged ≥21 years had 
a significantly higher AR (54.6%) than those under 21 
(14.9%), (risk ratio (RR) 3.7; 95% CI: 1.5–8.7, p=0.005). 
Respondents who smoked at the party also had a 
higher AR (41.7%) than non-smokers (15.9%); this 
result approached significance (RR 2.6, 95% CI 1.0–
6.8, p=0.05). No other variables had p <0.20 in uni-
variable analysis. Both factors remained significant in 
binomial regression: RR for age ≥21 years was 4.7 (95% 
CI: 2.1–10.2, p<0.0001), and for smoking at the party 
3.1 (95% CI: 1.6–6.0, p=0.001).
Table 3 shows the results of the symptoms analyses. 
Symptoms that were significantly more prevalent in the 
25 days after the party compared to the time of ques-
tionnaire completion were all URI-specific, namely sore 
throat (p=0.0016), cough (p=0.0047) and swollen cer-
vical lymph nodes (p=0.0253). 
Table 2
Characteristics of and risk factors for mumps disease among questionnaire respondents after a youth club party in a village, 
the Netherlands, 9 March 2012 (n=59)




Univariable analysis Binomial regression
Risk ratio 
(95% CI) p value
Risk ratio 
(95% CI) p value
Sex Male 30 8 27 1.5 (0.5-4.0) 0.534 NA NA
Female 29 5 18 Reference - - -
Age group <21 years 48 7 15 Reference 0.005 4.7 (2.1-10.2) <0.0001





Two doses 54 13 24 - - - -
Vaccinated but number of doses unknown 4 0 0 - - NA NA
Unknown status 1 0 0 - - - -
Education Full time 45 8 18 0.5 (0.1-2.0) 0.385 - -
Part time 8 3 38 1.1 (0.3-4.8) - NA NA




No 44 7 16 Reference 0.050 3.1 (1.6-6.0) 0.001
Yes 13 5 42 2.6 (1.0-6.8) - - -
CI: confidence interval; NA: not applicable; Reference: reference group; -: denotes a result that cannot be calculated
For one respondent, information on self-reported mumps symptoms was missing, therefore ARs and RRs are calculated with n=58 as 
denominator
Table 3
Prevalence of mild upper respiratory and non-respiratory symptoms in non-mumps cases after a youth club party in a 
village on 9 March 2012, and at time of questionnaire completion (May–June 2012), the Netherlands (n=46)
9 March – 3 April 2012 
(up to 25 days after the party)
4 May – 4 June 2012 
(at time of questionnaire 
completion)
McNemar chi-squared
n (%) n (%) p value
Upper respiratory illness symptoms
Runny nose 8 (17) 4 (9) 0.2059
Sore throat 11 (24) 1(2) 0.0016
Cough 8 (17) 1 (2) 0.0082
Swollen cervical lymph nodes 4 (9) 0 (0) 0.0455
Other symptoms
Stomach ache 2 (4) 1 (2) 0.5637
Myalgia 2 (4) 1 (2) 0.5637
Fever 3 (7) 1 (2) 0.3137




We describe a mumps outbreak with a 22% AR follow-
ing a party at a youth club where over 90% of outbreak 
investigation participants had received two doses of 
MMR vaccine. Smoking at the party and age ≥21 years 
were independent risk factors for mumps: smokers 
were three times more likely to become ill than non-
smokers, and individuals aged ≥21 years were almost 
five times more likely to become ill than individu-
als under 21. In addition to classic mumps disease, 
our results suggest that prevalence of mild URI was 
significantly higher around the time of the outbreak 
compared to a baseline prevalence at the time of ques-
tionnaire completion.
The observation that older age was a risk factor for 
mumps adds to previous evidence suggesting that 
waning of vaccine-derived immunity may prompt out-
breaks [11–14]. As our investigation was conducted 
online and several weeks after the outbreak, it was 
not possible to use serology to explore the role of pri-
mary versus secondary vaccine failure in more detail 
through avidity studies; however, IgG avidity testing 
following a mumps outbreak in a class of highly vacci-
nated 17–18 year-olds at a Korean school demonstrated 
that 73.3% of the cases had secondary vaccine failure 
[15]. Together with the previous studies that also found 
older age groups to be at increased risk in mumps out-
breaks, we conclude it is likely that waning immunity 
was the most likely explanation for older individuals 
being at higher risk of mumps in our study. A possi-
ble explanation for smoking being associated with 
increased risk could be that the practice of sharing cig-
arettes may transmit mumps virus via saliva; however, 
this behaviour was not commonly reported by study 
participants (data not shown). Alternative explanations 
could be that smoke may act as a vehicle for inhala-
tion of droplets carrying mumps virus, putting anyone 
who breathed the contaminated air at increased risk, 
or simply that smokers were in contact with each other 
more frequently than were non-smokers. As smoking 
indoors at the party was prohibited, it is likely that 
smokers congregated together outside the youth club 
to smoke, which would support the two latter explana-
tions. Nonetheless, smoking was not identified as a 
risk factor in similar outbreaks investigated previously 
[3,4].
Our AR of 22% seems high in comparison to other 
studies that found ARs of 2.2–3.6% in populations vac-
cinated with the Jeryl Lynn virus strain [5]. It is possi-
ble that our study overestimated AR for two reasons: 
firstly, mumps was self-reported and not confirmed 
serologically, allowing misclassification. However, in 
an outbreak context it can be expected that persons 
experiencing mumps-like symptoms within the incuba-
tion period are highly likely to be true cases. Secondly, 
mumps cases may have been more likely to partici-
pate, introducing bias. However, of the 16 cases noti-
fied to the MHS who did not respond to the survey and 
whose date of onset fell within the incubation period, 
ten reported attending the party. If these ten cases are 
included in the numerator and all other non-responders 
are assumed to be non-mumps cases (i.e. making the 
denominator all the people at the party, estimated to 
be 100), the estimated AR remains similar at 23%. Two 
studies in the Netherlands which investigated mumps 
outbreaks in highly-vaccinated populations following 
parties found comparable ARs in attendees of 16% 
[3] and 23% [4]. It is likely that intense crowding and 
perhaps environmental factors at parties contribute to 
high ARs. 
The finding of a significantly higher prevalence of mild 
URI in non-mumps cases after the party may be sug-
gestive that some infected individuals may present 
with mild disease and perhaps contribute to further 
transmission. This hypothesis is further supported 
by no similar apparent pattern for non-respiratory 
symptoms. However, care must be taken in interpre-
tation, as numbers were small and mild URI can be 
expected to be more common in early spring than in 
summer. Indeed, routine surveillance data suggest 
that in 2012, more upper respiratory pathogens were 
circulating in the Netherlands in weeks 10–14 than in 
weeks 18–23 (personal communication, Rianne van 
Gageldonk, September 2012), and unfortunately it was 
not possible to confirm or refute mumps virus infection 
serologically. 
In summary, our study suggests that intense social 
mixing, waning immunity and smoking contributed to 
an outbreak of mumps in a highly-vaccinated popula-
tion attending a party. Crowded social events appear to 
facilitate high attack rates among vaccinated popula-
tions, especially among age groups where there is no 
natural immunity and where several years have passed 
since vaccination. Our finding that mumps virus infec-
tion of vaccinated individuals may manifest as mild URI 
may have implications for transmission and warrants 
further investigation in future studies where serologi-
cal confirmation is a possibility. Ongoing studies in 
the Netherlands will study the role of asymptomatic or 
mild mumps infections in onwards transmission.
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